Gå ubegrenset med Magzter GOLD
Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare
Prøve GULL - Gratis
Does US cancer drug nod make Cipla attractive?
Mint Bangalore
|April 18, 2025
Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches
Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?
"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."
Denne historien er fra April 18, 2025-utgaven av Mint Bangalore.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Bangalore
Mint Bangalore
COP-30: Use carbon trading to win climate leadership
An efficient and credible carbon market can give India a chance to lead a global agenda that's fair to everyone
3 mins
September 15, 2025
Mint Bangalore
Hiring executive assistants to strike work-life balance
EAs are not just for top bosses anymore. Many more people are shelling out for assistants to help balance their lives
3 mins
September 15, 2025
Mint Bangalore
How fake paparazzi events fuel brand buzz across India
Strategy is to set up scenes looking spontaneous, with the paparazzi capturing the moment
2 mins
September 15, 2025
Mint Bangalore
ATM firm Indial's founder takes strategic role amid banktech push
Indial Payments, the largest white-label ATM operator in the country, is undergoing a leadership transition as it pivots towards digital services by launching a banking technology arm to offset sluggish ATM growth in India.
2 mins
September 15, 2025
Mint Bangalore
To curb smokeless tobacco use, India targets 100 high-burden districts
Consumption of smokeless tobacco, a leading cause for cancer, remains one of India's biggest public health challenges, with more than one in five people using such products.
2 mins
September 15, 2025
Mint Bangalore
Mercedes Expects Best Festive Season
The recent GST rate cut is likely to make the upcoming festive season the 'best-ever' for the luxury carmaker, but there is a need to cap road taxes levied by states on car purchases for long-term growth of the industry, Mercedes-Benz India managing director and chief executive officer Santosh Iyer said.
1 min
September 15, 2025
Mint Bangalore
Yuan versus the dollar: Propose a third option
As China attempts to globalize its legal tender; America guards the supremacy of its own and digital currencies gain traction, India should revive Keynes' idea of a global trade currency
2 mins
September 15, 2025
Mint Bangalore
US, Chinese officials hold talks in Spain
US and Chinese officials began talks in Madrid on Sunday on their strained trade ties, a looming divestiture deadline for Chinese short video app TikTok and Washington's demands that its allies place tariffs on China over its purchases of Russian oil.
1 min
September 15, 2025
Mint Bangalore
The Man, The Policies: What Makes Modi Special
The prime minister wants India's strong presence in the emerging new global system
3 mins
September 15, 2025
Mint Bangalore
Will We Disprove Yes Minister With Pension Reforms?
In Yes Minister, a TV satire on British politics, Sir Humphrey often stymied urgent reforms by setting up ‘interdepartmental committees.’
3 mins
September 15, 2025
Listen
Translate
Change font size